{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:39:59Z","timestamp":1793983199320,"version":"4.8.0"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41581-020-0333-2","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T13:02:36Z","timestamp":1598274156000},"page":"586-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":162,"title":["Challenges and novel therapies for vascular access in haemodialysis"],"prefix":"10.1038","volume":"16","author":[{"given":"Jeffrey H.","family":"Lawson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Niklason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabir","family":"Roy-Chaudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,24]]},"reference":[{"key":"333_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill, N. R. et al. Global prevalence of chronic kidney disease \u2013 a systematic review and meta-analysis. PLoS ONE 11, e0158765 (2016).","journal-title":"PLoS ONE"},{"key":"333_CR2","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. United States Renal Data System https:\/\/www.usrds.org\/2018\/view\/Default.aspx (2018)."},{"key":"333_CR3","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"GBD 2015 Mortality and Causes of Death Collaborators","year":"2016","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators. et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1459\u20131544 (2016).","journal-title":"Lancet"},{"key":"333_CR4","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage, T. et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385, 1972\u20131982 (2015).","journal-title":"Lancet"},{"key":"333_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1681\/ASN.2018050531","volume":"30","author":"KP McCullough","year":"2019","unstructured":"McCullough, K. P., Morgenstern, H., Saran, R., Herman, W. H. & Robinson, B. M. Projecting ESRD incidence and prevalence in the United States through 2030. J. Am. Soc. Nephrol. 30, 127\u2013135 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"333_CR6","unstructured":"International Society of Nephrology. ISN Global Kidney Health Atlas. 2nd ed. https:\/\/www.theisn.org\/global-atlas (2019)."},{"key":"333_CR7","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1377\/hlthaff.2012.0368","volume":"31","author":"S Swaminathan","year":"2012","unstructured":"Swaminathan, S., Mor, V., Mehrotra, R. & Trivedi, A. Medicare\u2019s payment strategy for end-stage renal disease now embraces bundled payment and pay-for-performance to cut costs. Health Aff. 31, 2051\u20132058 (2012).","journal-title":"Health Aff."},{"key":"333_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/sdi.12675","volume":"31","author":"L Golestaneh","year":"2018","unstructured":"Golestaneh, L. Decreasing hospitalizations in patients on hemodialysis: time for a paradigm shift. Semin. Dial. 31, 278\u2013288 (2018).","journal-title":"Semin. Dial."},{"key":"333_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012062","volume":"6","author":"JK Eriksson","year":"2016","unstructured":"Eriksson, J. K., Neovius, M., Jacobson, S. H., Elinder, C.-G. & Hylander, B. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden. BMJ Open 6, e012062 (2016).","journal-title":"BMJ Open"},{"key":"333_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1471-2369-15-161","volume":"15","author":"FX Liu","year":"2014","unstructured":"Liu, F. X., Treharne, C., Culleton, B., Crowe, L. & Arici, M. The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis. BMC Nephrol. 15, 161 (2014).","journal-title":"BMC Nephrol."},{"key":"333_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000450672","volume":"189","author":"AA Kaplan","year":"2016","unstructured":"Kaplan, A. A. Peritoneal dialysis or hemodialysis: present and future trends in the United States. Contrib. Nephrol. 189, 61\u201364 (2016).","journal-title":"Contrib. Nephrol."},{"key":"333_CR12","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/ki.1993.153","volume":"43","author":"HI Feldman","year":"1993","unstructured":"Feldman, H. I. et al. Hemodialysis vascular access morbidity in the United States. Kidney Int. 43, 1091\u20131096 (1993).","journal-title":"Kidney Int."},{"key":"333_CR13","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.2215\/CJN.03050315","volume":"10","author":"LS Dalrymple","year":"2015","unstructured":"Dalrymple, L. S. et al. Risk factors for infection-related hospitalization in in-center hemodialysis. Clin. J. Am. Soc. Nephrol. 10, 2170\u20132180 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"333_CR14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1681\/ASN.V74523","volume":"7","author":"HI Feldman","year":"1996","unstructured":"Feldman, H. I., Kobrin, S. & Wasserstein, A. Hemodialysis vascular access morbidity. J. Am. Soc. Nephrol. 7, 523\u2013535 (1996).","journal-title":"J. Am. Soc. Nephrol."},{"key":"333_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1053\/j.ajkd.2018.01.034","volume":"72","author":"M Thamer","year":"2018","unstructured":"Thamer, M. et al. Medicare costs associated with arteriovenous fistulas among US hemodialysis patients. Am. J. Kidney Dis. 72, 10\u201318 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"333_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJM196611172752002","volume":"275","author":"MJ Brescia","year":"1966","unstructured":"Brescia, M. J., Cimino, J. E., Appel, K. & Hurwich, B. J. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N. Engl. J. Med. 275, 1089\u20131092 (1966).","journal-title":"N. Engl. J. Med."},{"key":"333_CR17","first-page":"511","volume":"10","author":"MA Enzler","year":"1996","unstructured":"Enzler, M. A., Rajmon, T., Lachat, M. & Largiader, F. Long-term function of vascular access for hemodialysis. Clin. Transplant. 10, 511\u2013515 (1996).","journal-title":"Clin. Transplant."},{"key":"333_CR18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1053\/j.ajkd.2014.12.014","volume":"65","author":"RL Pisoni","year":"2015","unstructured":"Pisoni, R. L., Zepel, L., Port, F. K. & Robinson, B. M. Trends in US vascular access use, patient preferences, and related practices: an update from the US DOPPS practice monitor with international comparisons. Am. J. Kidney Dis. 65, 905\u2013915 (2015).","journal-title":"Am. J. Kidney Dis."},{"key":"333_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1053\/j.ajkd.2017.09.012","volume":"71","author":"RL Pisoni","year":"2018","unstructured":"Pisoni, R. L. et al. International differences in the location and use of arteriovenous accesses created for hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am. J. Kidney Dis. 71, 469\u2013478 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"333_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ejvs.2017.06.024","volume":"54","author":"LC Bylsma","year":"2017","unstructured":"Bylsma, L. C., Gage, S. M., Reichert, H., Dahl, S. L. M. & Lawson, J. H. Arteriovenous fistulae for haemodialysis: a systematic review and meta-analysis of efficacy and safety outcomes. Eur. J. Vasc. Endovasc. Surg. 54, 513\u2013522 (2017).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"333_CR21","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1001\/jama.299.18.2164","volume":"299","author":"LM Dember","year":"2008","unstructured":"Dember, L. M. et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 299, 2164\u20132171 (2008).","journal-title":"JAMA"},{"key":"333_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1053\/j.ajkd.2018.03.023","volume":"72","author":"T Lee","year":"2018","unstructured":"Lee, T., Qian, J., Thamer, M. & Allon, M. Tradeoffs in vascular access selection in elderly patients initiating hemodialysis with a catheter. Am. J. Kidney Dis. 72, 509\u2013518 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"333_CR23","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1053\/j.ajkd.2007.07.019","volume":"50","author":"P Roy-Chaudhury","year":"2007","unstructured":"Roy-Chaudhury, P. et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am. J. Kidney Dis. 50, 782\u2013790 (2007).","journal-title":"Am. J. Kidney Dis."},{"key":"333_CR24","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1681\/ASN.2005050615","volume":"17","author":"P Roy-Chaudhury","year":"2006","unstructured":"Roy-Chaudhury, P., Sukhatme, V. P. & Cheung, A. K. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J. Am. Soc. Nephrol. 17, 1112\u20131127 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"333_CR25","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/sj.ki.5001747","volume":"70","author":"BS Dixon","year":"2006","unstructured":"Dixon, B. S. Why don\u2019t fistulas mature? Kidney Int. 70, 1413\u20131422 (2006).","journal-title":"Kidney Int."},{"key":"333_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1053\/j.ackd.2009.06.009","volume":"16","author":"T Lee","year":"2009","unstructured":"Lee, T. & Roy-Chaudhury, P. Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv. Chronic Kidney Dis. 16, 329\u2013338 (2009).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"333_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/sdi.12045","volume":"26","author":"E Rajabi-Jagahrgh","year":"2013","unstructured":"Rajabi-Jagahrgh, E. et al. Influence of temporal variation in wall shear stress on intima-media thickening in arteriovenous fistulae. Semin. Dial. 26, 511\u2013519 (2013).","journal-title":"Semin. Dial."},{"key":"333_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/01.RVI.0000217928.43396.35","volume":"17","author":"A Falk","year":"2006","unstructured":"Falk, A. Maintenance and salvage of arteriovenous fistulas. J. Vasc. Interv. Radiol. 17, 807\u2013813 (2006).","journal-title":"J. Vasc. Interv. Radiol."},{"key":"333_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5301\/jva.5000723","volume":"18","author":"S Yang","year":"2017","unstructured":"Yang, S., Lok, C., Arnold, R., Rajan, D. & Glickman, M. Comparison of post-creation procedures and costs between surgical and an endovascular approach to arteriovenous fistula creation. J. Vasc. Access. 18, 8\u201314 (2017).","journal-title":"J. Vasc. Access."},{"key":"333_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jvs.2016.02.033","volume":"64","author":"JC Harms","year":"2016","unstructured":"Harms, J. C., Rangarajan, S., Young, C. J., Barker-Finkel, J. & Allon, M. Outcomes of arteriovenous fistulas and grafts with or without intervention before successful use. J. Vasc. Surg. 64, 155\u2013162 (2016).","journal-title":"J. Vasc. Surg."},{"key":"333_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1053\/j.ajkd.2007.06.006","volume":"50","author":"E Lacson","year":"2007","unstructured":"Lacson, E., Lazarus, J. M., Himmelfarb, J., Ikizler, T. A. & Hakim, R. M. Balancing Fistula First with Catheters Last. Am. J. Kidney Dis. 50, 379\u2013395 (2007).","journal-title":"Am. J. Kidney Dis."},{"key":"333_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5301\/jva.5000111","volume":"14","author":"A Rajput","year":"2013","unstructured":"Rajput, A. et al. Venous aneurysms in autogenous hemodialysis fistulas: is there an association with venous outflow stenosis. J. Vasc. Access. 14, 126\u2013130 (2013).","journal-title":"J. Vasc. Access."},{"key":"333_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/ckj\/sfv042","volume":"8","author":"A Mudoni","year":"2015","unstructured":"Mudoni, A. et al. Aneurysms and pseudoaneurysms in dialysis access. Clin. Kidney J. 8, 363\u2013367 (2015).","journal-title":"Clin. Kidney J."},{"key":"333_CR34","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.jvs.2010.11.100","volume":"53","author":"G Pasklinsky","year":"2011","unstructured":"Pasklinsky, G. et al. Management of true aneurysms of hemodialysis access fistulas. J. Vasc. Surg. 53, 1291\u20131297 (2011).","journal-title":"J. Vasc. Surg."},{"key":"333_CR35","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1177\/1538574414561229","volume":"48","author":"D Valenti","year":"2014","unstructured":"Valenti, D., Mistry, H. & Stephenson, M. A novel classification system for autogenous arteriovenous fistula aneurysms in renal access patients. Vasc. Endovasc. Surg. 48, 491\u2013496 (2014).","journal-title":"Vasc. Endovasc. Surg."},{"key":"333_CR36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000355548","volume":"124","author":"A Jankovic","year":"2013","unstructured":"Jankovic, A. et al. Arteriovenous fistula aneurysm in patients on regular hemodialysis: prevalence and risk factors. Nephron. Clin. Pract. 124, 94\u201398 (2013).","journal-title":"Nephron. Clin. Pract."},{"key":"333_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.33160\/yam.2018.06.008","volume":"61","author":"S Shiraya","year":"2018","unstructured":"Shiraya, S. et al. Successful surgical remodeling of a giant venous aneurysm formed in an autogenous arteriovenous fistula: a case report. Yonago Acta Med. 61, 142\u2013144 (2018).","journal-title":"Yonago Acta Med."},{"key":"333_CR38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ehj.2018.10.007","volume":"70","author":"MA Saleh","year":"2018","unstructured":"Saleh, M. A., El Kilany, W. M., Keddis, V. W. & El Said, T. W. Effect of high flow arteriovenous fistula on cardiac function in hemodialysis patients. Egypt. Heart J. 70, 337\u2013341 (2018).","journal-title":"Egypt. Heart J."},{"key":"333_CR39","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/sdi.12366","volume":"28","author":"A Sequeira","year":"2015","unstructured":"Sequeira, A. & Tan, T.-W. Complications of a high-flow access and its management. Semin. Dial. 28, 533\u2013543 (2015).","journal-title":"Semin. Dial."},{"key":"333_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.5301\/jva.5000412","volume":"16","author":"J Al Shakarchi","year":"2015","unstructured":"Al Shakarchi, J., Houston, G. & Inston, N. Early cannulation grafts for haemodialysis: a systematic review. J. Vasc. Access. 16, 493\u2013497 (2015).","journal-title":"J. Vasc. Access."},{"key":"333_CR41","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1681\/ASN.2012070643","volume":"24","author":"P Ravani","year":"2013","unstructured":"Ravani, P. et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J. Am. Soc. Nephrol. 24, 465\u2013473 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"333_CR42","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2215\/CJN.12181116","volume":"12","author":"P Ravani","year":"2017","unstructured":"Ravani, P. et al. Examining the association between hemodialysis access type and mortality: the role of access complications. Clin. J. Am. Soc. Nephrol. 12, 955\u2013964 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"333_CR43","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1053\/j.ajkd.2017.11.020","volume":"71","author":"KJ Woodside","year":"2018","unstructured":"Woodside, K. J. et al. Arteriovenous fistula maturation in prevalent hemodialysis patients in the United States: a national study. Am. J. Kidney Dis. 71, 793\u2013801 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"333_CR44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S1073-4449(12)80044-6","volume":"1","author":"GA Beathard","year":"1994","unstructured":"Beathard, G. A. The treatment of vascular access graft dysfunction: a nephrologist\u2019s view and experience. Adv. Ren. Replace. Ther. 1, 131\u2013147 (1994).","journal-title":"Adv. Ren. Replace. Ther."},{"key":"333_CR45","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1586\/erc.12.33","volume":"10","author":"MJ Collins","year":"2012","unstructured":"Collins, M. J. et al. Therapeutic strategies to combat neointimal hyperplasia in vascular grafts. Expert. Rev. Cardiovasc. Ther. 10, 635\u2013647 (2012).","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"333_CR46","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1253\/circj.CJ-10-0495","volume":"74","author":"A Muto","year":"2010","unstructured":"Muto, A., Model, L., Ziegler, K., Eghbalieh, S. D. D. & Dardik, A. Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies. Circ. J. 74, 1501\u20131512 (2010).","journal-title":"Circ. J."},{"key":"333_CR47","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/0002-9610(86)90249-7","volume":"152","author":"GM Kherlakian","year":"1986","unstructured":"Kherlakian, G. M., Roedersheimer, L. R., Arbaugh, J. J., Newmark, K. J. & King, L. R. Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis. Am. J. Surg. 152, 238\u2013243 (1986).","journal-title":"Am. J. Surg."},{"key":"333_CR48","doi-asserted-by":"publisher","first-page":"467","DOI":"10.5301\/jva.5000390","volume":"16","author":"GGD Maytham","year":"2015","unstructured":"Maytham, G. G. D., Sran, H. K. & Chemla, E. S. The use of the early cannulation prosthetic graft (Acuseal) for angioaccess for haemodialysis. J. Vasc. Access. 16, 467\u2013471 (2015).","journal-title":"J. Vasc. Access."},{"key":"333_CR49","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0272-6386(04)01078-9","volume":"44","author":"M Allon","year":"2004","unstructured":"Allon, M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am. J. Kidney Dis. 44, 779\u2013791 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"333_CR50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1525-139X.2007.00379.x","volume":"21","author":"RM Klevens","year":"2008","unstructured":"Klevens, R. M. et al. Dialysis surveillance report: National Healthcare Safety Network (NHSN)\u2013data summary for 2006. Semin. Dial. 21, 24\u201328 (2008).","journal-title":"Semin. Dial."},{"key":"333_CR51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1053\/j.ajkd.2010.08.028","volume":"57","author":"JR Lynch","year":"2011","unstructured":"Lynch, J. R., Wasse, H., Armistead, N.C. & McClellan, W. M. Achieving the goal of the fistula first breakthrough initiative for prevalent maintenance hemodialysis patients. Am. J. Kidney Dis. 57, 78\u201389 (2011).","journal-title":"Am. J. Kidney Dis."},{"key":"333_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1023\/A:1011272632286","volume":"11","author":"CM Clase","year":"2001","unstructured":"Clase, C. M., Crowther, M. A., Ingram, A. J. & Cina, C. S. Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review. J. Thromb. Thrombolysis 11, 127\u2013136 (2001).","journal-title":"J. Thromb. Thrombolysis"},{"key":"333_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1345\/aph.1C105","volume":"37","author":"JM Zacharias","year":"2003","unstructured":"Zacharias, J. M., Weatherston, C. P., Spewak, C. R. & Vercaigne, L. M. Alteplase versus urokinase for occluded hemodialysis catheters. Ann. Pharmacother. 37, 27\u201333 (2003).","journal-title":"Ann. Pharmacother."},{"key":"333_CR54","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/00002480-199907000-00019","volume":"45","author":"SV Jassal","year":"1999","unstructured":"Jassal, S. V., Pierratos, A. & Roscoe, J. M. Venous stenosis and thrombosis associated with the use of internal jugular vein catheters for hemodialysis. ASAIO J. 45, 356\u2013359 (1999).","journal-title":"ASAIO J."},{"key":"333_CR55","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0741-5214(97)70014-4","volume":"26","author":"TC Hodges","year":"1997","unstructured":"Hodges, T. C. et al. Longitudinal comparison of dialysis access methods: risk factors for failure. J. Vasc. Surg. 26, 1009\u20131019 (1997).","journal-title":"J. Vasc. Surg."},{"key":"333_CR56","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.2215\/CJN.06050710","volume":"5","author":"M Allon","year":"2010","unstructured":"Allon, M. & Lok, C. E. Dialysis fistula or graft: the role for randomized clinical trials. Clin. J. Am. Soc. Nephrol. 5, 2348\u20132354 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"333_CR57","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.2215\/CJN.06660518","volume":"13","author":"E Lin","year":"2018","unstructured":"Lin, E., Mell, M. W., Winkelmayer, W. C. & Erickson, K. F. Health insurance in the first 3 months of hemodialysis and early vascular access. Clin. J. Am. Soc. Nephrol. 13, 1866\u20131875 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"333_CR58","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0272-6386(04)01101-1","volume":"44","author":"HC Rayner","year":"2004","unstructured":"Rayner, H. C. et al. Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K\/DOQI) clinical practice guidelines. Am. J. Kidney Dis. 44, 22\u201326 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"333_CR59","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1525-139X.2009.00675.x","volume":"23","author":"HC Rayner","year":"2010","unstructured":"Rayner, H. C. & Pisoni, R. L. The increasing use of hemodialysis catheters: evidence from the DOPPS on its significance and ways to reverse it. Semin. Dial. 23, 6\u201310 (2010).","journal-title":"Semin. Dial."},{"key":"333_CR60","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1053\/ajkd.2002.31405","volume":"39","author":"KB Stevenson","year":"2002","unstructured":"Stevenson, K. B. et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am. J. Kidney Dis. 39, 549\u2013555 (2002).","journal-title":"Am. J. Kidney Dis."},{"key":"333_CR61","first-page":"155","volume":"11","author":"JA Akoh","year":"2010","unstructured":"Akoh, J. A. & Patel, N. Infection of hemodialysis arteriovenous grafts. J. Vasc. 11, 155\u2013158 (2010).","journal-title":"J. Vasc."},{"key":"333_CR62","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jamcollsurg.2005.03.040","volume":"201","author":"HE Katzman","year":"2005","unstructured":"Katzman, H. E., Glickman, M. H., Schild, A. F., Fujitani, R. M. & Lawson, J. H. Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft. J. Am. Coll. Surg. 201, 223\u2013230 (2005).","journal-title":"J. Am. Coll. Surg."},{"key":"333_CR63","volume":"3","author":"LM Miller","year":"2016","unstructured":"Miller, L. M. et al. Hemodialysis tunneled catheter-related infections. Can. J. Kidney Health Dis. 3, 2054358116669129 (2016).","journal-title":"Can. J. Kidney Health Dis."},{"key":"333_CR64","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/qjmed\/hcs143","volume":"105","author":"BD Bray","year":"2012","unstructured":"Bray, B. D. et al. Vascular access type and risk of mortality in a national prospective cohort of haemodialysis patients. QJM 105, 1097\u20131103 (2012).","journal-title":"QJM"},{"key":"333_CR65","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1097\/CCM.0000000000003342","volume":"46","author":"CJ Paoli","year":"2018","unstructured":"Paoli, C. J., Reynolds, M. A., Sinha, M., Gitlin, M. & Crouser, E. Epidemiology and costs of sepsis in the United States\u2013an analysis based on timing of diagnosis and severity level. Crit. Care Med. 46, 1889\u20131897 (2018).","journal-title":"Crit. Care Med."},{"key":"333_CR66","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000490624","volume":"48","author":"S Shah","year":"2018","unstructured":"Shah, S., Leonard, A. C., Meganathan, K., Christianson, A. L. & Thakar, C. V. Gender and racial disparities in initial hemodialysis access and outcomes in incident end-stage renal disease patients. Am. J. Nephrol. 48, 4\u201314 (2018).","journal-title":"Am. J. Nephrol."},{"key":"333_CR67","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2215\/CJN.03480807","volume":"3","author":"WJ Peterson","year":"2008","unstructured":"Peterson, W. J., Barker, J. & Allon, M. Disparities in fistula maturation persist despite preoperative vascular mapping. Clin. J. Am. Soc. Nephrol. 3, 437\u2013441 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"333_CR68","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/sdi.12040","volume":"26","author":"H-W Lee","year":"2013","unstructured":"Lee, H.-W. & Allon, M. When should a patient receive an arteriovenous graft rather than a fistula? Semin. Dial. 26, 6\u201310 (2013).","journal-title":"Semin. Dial."},{"key":"333_CR69","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jamasurg.2015.0287","volume":"150","author":"DS Zarkowsky","year":"2015","unstructured":"Zarkowsky, D. S. et al. Racial\/ethnic disparities associated with initial hemodialysis access. JAMA Surg. 150, 529\u2013536 (2015).","journal-title":"JAMA Surg."},{"key":"333_CR70","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000441804","volume":"42","author":"R Nee","year":"2015","unstructured":"Nee, R. et al. Impact of poverty and health care insurance on arteriovenous fistula use among incident hemodialysis patients. Am. J. Nephrol. 42, 328\u2013336 (2015).","journal-title":"Am. J. Nephrol."},{"key":"333_CR71","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/hdi.12099","volume":"18","author":"BK Patibandla","year":"2014","unstructured":"Patibandla, B. K. et al. Disparities in arteriovenous fistula placement in older hemodialysis patients. Hemodial. Int. 18, 118\u2013126 (2014).","journal-title":"Hemodial. Int."},{"key":"333_CR72","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.avsg.2019.08.068","volume":"62","author":"TP Copeland","year":"2020","unstructured":"Copeland, T. P., Hye, R. J., Lawrence, P. F. & Woo, K. Association of race and ethnicity with vascular access type selection and outcomes. Ann. Vasc. Surg. 62, 142\u2013147 (2020).","journal-title":"Ann. Vasc. Surg."},{"key":"333_CR73","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1681\/ASN.2016060707","volume":"28","author":"A Al-Balas","year":"2017","unstructured":"Al-Balas, A. et al. The clinical and economic effect of vascular access selection in patients initiating hemodialysis with a catheter. J. Am. Soc. Nephrol. 28, 3679\u20133687 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"333_CR74","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/ndt\/gfp462","volume":"25","author":"MF Kheda","year":"2010","unstructured":"Kheda, M. F. et al. Influence of arterial elasticity and vessel dilatation on arteriovenous fistula maturation: a prospective cohort study. Nephrol. Dial. Transpl. 25, 525\u2013531 (2010).","journal-title":"Nephrol. Dial. Transpl."},{"key":"333_CR75","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1046\/j.1523-1755.2003.00210.x","volume":"64","author":"GA Beathard","year":"2003","unstructured":"Beathard, G. A., Arnold, P., Jackson, J. & Litchfield, T. Aggressive treatment of early fistula failure. Kidney Int. 64, 1487\u20131494 (2003).","journal-title":"Kidney Int."},{"key":"333_CR76","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jvs.2011.07.090","volume":"55","author":"A Bharat","year":"2012","unstructured":"Bharat, A., Jaenicke, M. & Shenoy, S. A novel technique of vascular anastomosis to prevent juxta-anastomotic stenosis following arteriovenous fistula creation. J. Vasc. Surg. 55, 274\u2013280 (2012).","journal-title":"J. Vasc. Surg."},{"key":"333_CR77","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.jvs.2015.07.074","volume":"62","author":"N Sadaghianloo","year":"2015","unstructured":"Sadaghianloo, N. et al. Increased reintervention in radial-cephalic arteriovenous fistulas with anastomotic angles of less than 30 degrees. J. Vasc. Surg. 62, 1583\u20131589 (2015).","journal-title":"J. Vasc. Surg."},{"key":"333_CR78","doi-asserted-by":"publisher","first-page":"152S","DOI":"10.1016\/j.jvs.2018.04.045","volume":"68","author":"RW Corbett","year":"2018","unstructured":"Corbett, R. W. et al. Heterogeneity in the nonplanarity and arterial curvature of arteriovenous fistulas in vivo. J. Vasc. Surg. 68, 152S\u2013163S (2018).","journal-title":"J. Vasc. Surg."},{"key":"333_CR79","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5301\/jva.5000527","volume":"17","author":"E Chemla","year":"2016","unstructured":"Chemla, E., Velazquez, C. C., D\u2019Abate, F., Ramachandran, V. & Maytham, G. Arteriovenous fistula construction with the VasQ external support device: a pilot study. J. Vasc. Access. 17, 243\u2013248 (2016).","journal-title":"J. Vasc. Access."},{"key":"333_CR80","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03242343 (2020)."},{"key":"333_CR81","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5301\/jva.5000169","volume":"15","author":"E Chemla","year":"2014","unstructured":"Chemla, E. et al. Arteriovenous fistula creation using the Optiflow vascular anastomotic connector: the OPEN (Optiflow PatEncy and MaturatioN) study. J. Vasc. Access. 15, 38\u201344 (2014).","journal-title":"J. Vasc. Access."},{"key":"333_CR82","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jvs.2014.11.082","volume":"61","author":"M Nikam","year":"2015","unstructured":"Nikam, M. et al. Prospective controlled pilot study of arteriovenous fistula placement using the novel Optiflow device. J. Vasc. Surg. 61, 1020\u20131025 (2015).","journal-title":"J. Vasc. Surg."},{"key":"333_CR83","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/nep.12394","volume":"20","author":"L Jia","year":"2015","unstructured":"Jia, L. et al. Effects of wall shear stress in venous neointimal hyperplasia of arteriovenous fistulae. Nephrology 20, 335\u2013342 (2015).","journal-title":"Nephrology"},{"key":"333_CR84","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/1874303X01407010033","volume":"7","author":"MK Fitts","year":"2014","unstructured":"Fitts, M. K., Pike, D. B., Anderson, K. & Shiu, Y.-T. Hemodynamic shear stress and endothelial dysfunction in hemodialysis access. Open Urol. Nephrol. J. 7, 33\u201344 (2014).","journal-title":"Open Urol. Nephrol. J."},{"key":"333_CR85","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1681\/ASN.2017111225","volume":"29","author":"ML Robbin","year":"2018","unstructured":"Robbin, M. L. et al. Prediction of arteriovenous fistula clinical maturation from postoperative ultrasound measurements: findings from the Hemodialysis Fistula Maturation Study. J. Am. Soc. Nephrol. 29, 2735\u20132744 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"333_CR86","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/MAT.0000000000000240","volume":"61","author":"HM Loree II","year":"2015","unstructured":"Loree, H. M. II et al. In vitro study of a medical device to enhance arteriovenous fistula eligibility and maturation. ASAIO J. 61, 480\u2013486 (2015).","journal-title":"ASAIO J."},{"key":"333_CR87","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1161\/ATVBAHA.118.310223","volume":"38","author":"MW Majesky","year":"2018","unstructured":"Majesky, M. W. Vascular development. Arterioscler. Thromb. Vasc. Biol. 38, e17\u2013e24 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"333_CR88","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.jvs.2009.07.108","volume":"50","author":"MS Conte","year":"2009","unstructured":"Conte, M. S. et al. Multicenter phase I\/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study. J. Vasc. Surg. 50, 1359\u20131368.e1 (2009).","journal-title":"J. Vasc. Surg."},{"key":"333_CR89","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.jvs.2011.05.005","volume":"54","author":"MS Conte","year":"2011","unstructured":"Conte, M. S., Nugent, H. M., Gaccione, P., Roy-Chaudhury, P. & Lawson, J. H. Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. J. Vasc. Surg. 54, 1383\u20131389 (2011).","journal-title":"J. Vasc. Surg."},{"key":"333_CR90","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5301\/jva.5000125","volume":"14","author":"EK Peden","year":"2013","unstructured":"Peden, E. K. et al. A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation. J. Vasc. Access. 14, 143\u2013151 (2013).","journal-title":"J. Vasc. Access."},{"key":"333_CR91","doi-asserted-by":"publisher","first-page":"376","DOI":"10.5301\/jva.5000235","volume":"15","author":"AJ Dwivedi","year":"2014","unstructured":"Dwivedi, A. J. et al. Application of human type I pancreatic elastase (PRT-201) to the venous anastomosis of arteriovenous grafts in patients with chronic kidney disease. J. Vasc. Access. 15, 376\u2013384 (2014).","journal-title":"J. Vasc. Access."},{"key":"333_CR92","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jvs.2018.04.068","volume":"69","author":"AJ Bleyer","year":"2019","unstructured":"Bleyer, A. J. et al. A randomized trial of vonapanitase (PATENCY-1) to promote radiocephalic fistula patency and use for hemodialysis. J. Vasc. Surg. 69, 507\u2013515 (2019).","journal-title":"J. Vasc. Surg."},{"key":"333_CR93","unstructured":"Proteon Therapeutics. Proteon Therapeutics announces top-line results from phase 3 PATENCY-2 clinical trial of vonapanitase in radiocephalic arteriovenous fistulas: investigational vonapanitase did not meet co-primary endpoints. https:\/\/www.globenewswire.com\/news-release\/2019\/03\/28\/1781199\/0\/en\/Proteon-Therapeutics-Announces-Top-Line-Results-From-Phase-3-PATENCY-2-Clinical-Trial-of-Vonapanitase-in-Radiocephalic-Arteriovenous-Fistulas.html (2019)."},{"key":"333_CR94","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1590\/2175-8239-jbn-2018-0170","volume":"41","author":"G Kazemzadeh","year":"2019","unstructured":"Kazemzadeh, G., Saberi, A., Manani, R., Sadeghipour, F. & Rahmani, A. Effect of local papaverine on arteriovenous fistula maturation in patients with end-stage renal disease. J. Bras. Nefrol. 41, 185\u2013192 (2019).","journal-title":"J. Bras. Nefrol."},{"key":"333_CR95","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02513303 (2020)."},{"key":"333_CR96","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/ndt\/gfr667","volume":"27","author":"WD Paulson","year":"2012","unstructured":"Paulson, W. D. et al. Safety and efficacy of local periadventitial delivery of sirolimus for improving hemodialysis graft patency: first human experience with a sirolimus-eluting collagen membrane (Coll-R). Nephrol. Dial. Transpl. 27, 1219\u20131224 (2012).","journal-title":"Nephrol. Dial. Transpl."},{"key":"333_CR97","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.avsg.2012.06.009","volume":"27","author":"T Derderian","year":"2013","unstructured":"Derderian, T. et al. To BAM or not to BAM?: a closer look at balloon-assisted maturation. Ann. Vasc. Surg. 27, 104\u2013109 (2013).","journal-title":"Ann. Vasc. Surg."},{"key":"333_CR98","doi-asserted-by":"publisher","first-page":"272","DOI":"10.4174\/astr.2016.90.5.272","volume":"90","author":"SC Park","year":"2016","unstructured":"Park, S. C., Ko, S. Y., Kim, J. II, Moon, I. S. & Kim, S. D. Balloon-assisted maturation for arteriovenous fistula maturation failure: an early period experience. Ann. Surg. Treat. Res. 90, 272\u2013278 (2016).","journal-title":"Ann. Surg. Treat. Res."},{"key":"333_CR99","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.avsg.2016.08.022","volume":"41","author":"SA Rizvi","year":"2017","unstructured":"Rizvi, S. A. et al. The clinical efficacy of balloon-assisted maturation of autogenous arteriovenous fistulae. Ann. Vasc. Surg. 41, 41\u201345 (2017).","journal-title":"Ann. Vasc. Surg."},{"key":"333_CR100","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.avsg.2013.12.030","volume":"28","author":"T DerDerian","year":"2014","unstructured":"DerDerian, T., Hingorani, A., Boniviscage, P., Carollo, A. & Ascher, E. Acute complications after balloon-assisted maturation. Ann. Vasc. Surg. 28, 1275\u20131279 (2014).","journal-title":"Ann. Vasc. Surg."},{"key":"333_CR101","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1129729818793102","volume":"20","author":"D Patane","year":"2019","unstructured":"Patane, D. et al. Treatment of juxta-anastomotic stenoses for failing distal radiocephalic arteriovenous fistulas: drug-coated balloons versus angioplasty. J. Vasc. Access 20, 209\u2013216 (2019).","journal-title":"J. Vasc. Access"},{"key":"333_CR102","doi-asserted-by":"publisher","first-page":"388","DOI":"10.5301\/jva.5000396","volume":"16","author":"JJ Swinnen","year":"2015","unstructured":"Swinnen, J. J., Zahid, A. & Burgess, D. C. A. Paclitaxel drug-eluting balloons to recurrent in-stent stenoses in autogenous dialysis fistulas: a retrospective study. J. Vasc. Access 16, 388\u2013393 (2015).","journal-title":"J. Vasc. Access"},{"key":"333_CR103","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1053\/j.semvascsurg.2016.08.002","volume":"29","author":"A Boitet","year":"2016","unstructured":"Boitet, A. et al. Drug-coated balloon angioplasty for dialysis access fistula stenosis. Semin. Vasc. Surg. 29, 178\u2013185 (2016).","journal-title":"Semin. Vasc. Surg."},{"key":"333_CR104","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2215\/CJN.14231217","volume":"13","author":"SO Trerotola","year":"2018","unstructured":"Trerotola, S. O., Lawson, J., Roy-Chaudhury, P. & Saad, T. F. Drug coated balloon angioplasty in failing AV fistulas. Clin. J. Am. Soc. Nephrol. 13, 1215\u20131224 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"333_CR105","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03041467 (2020)."},{"key":"333_CR106","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jvir.2017.10.015","volume":"29","author":"JE Hull","year":"2018","unstructured":"Hull, J. E. et al. The pivotal multicenter trial of ultrasound-guided percutaneous arteriovenous fistula creation for hemodialysis access. J. Vasc. Interv. Radiol. 29, 149\u2013158.e5 (2018).","journal-title":"J. Vasc. Interv. Radiol."},{"key":"333_CR107","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/hdi.12738","volume":"23","author":"H Hebibi","year":"2019","unstructured":"Hebibi, H., Achiche, J., Franco, G. & Rottembourg, J. Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys\u00ae vascular access system. Hemodial. Int. 23, 167\u2013172 (2019).","journal-title":"Hemodial. Int."},{"key":"333_CR108","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.avsg.2019.02.023","volume":"60","author":"TL Berland","year":"2019","unstructured":"Berland, T. L., Clement, J., Griffin, J., Westin, G. G. & Ebner, A. Endovascular creation of arteriovenous fistulae for hemodialysis access with a 4 Fr device: clinical experience from the EASE study. Ann. Vasc. Surg. 60, 182\u2013192 (2019).","journal-title":"Ann. Vasc. Surg."},{"key":"333_CR109","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1053\/j.ajkd.2017.03.026","volume":"70","author":"CE Lok","year":"2017","unstructured":"Lok, C. E. et al. Endovascular proximal forearm arteriovenous fistula for hemodialysis access: results of the prospective, multicenter novel endovascular access trial (NEAT). Am. J. Kidney Dis. 70, 486\u2013497 (2017).","journal-title":"Am. J. Kidney Dis."},{"key":"333_CR110","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.jvir.2018.05.014","volume":"29","author":"RJG Arnold","year":"2018","unstructured":"Arnold, R. J. G. et al. Comparison between surgical and endovascular hemodialysis arteriovenous fistula interventions and associated costs. J. Vasc. Interv. Radiol. 29, 1558\u20131566.e2 (2018).","journal-title":"J. Vasc. Interv. Radiol."},{"key":"333_CR111","doi-asserted-by":"publisher","DOI":"10.1177\/1129729819897168","author":"N Inston","year":"2020","unstructured":"Inston, N., Khawaja, A., Tullett, K. & Jones, R. WavelinQ created arteriovenous fistulas versus surgical radiocephalic arteriovenous fistulas? A single-centre observational study. J. Vasc. Access https:\/\/doi.org\/10.1177\/1129729819897168 (2020).","journal-title":"J. Vasc. Access"},{"key":"333_CR112","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa0805840","volume":"360","author":"BS Dixon","year":"2009","unstructured":"Dixon, B. S. et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N. Engl. J. Med. 360, 2191\u20132201 (2009).","journal-title":"N. Engl. J. Med."},{"key":"333_CR113","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.avsg.2017.09.017","volume":"49","author":"J Freeman","year":"2018","unstructured":"Freeman, J. et al. Sustained thromboresistant bioactivity with reduced intimal hyperplasia of heparin-bonded polytetrafluoroethylene Propaten graft in a chronic canine femoral artery bypass model. Ann. Vasc. Surg. 49, 295\u2013303 (2018).","journal-title":"Ann. Vasc. Surg."},{"key":"333_CR114","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/j.semvascsurg.2016.08.003","volume":"29","author":"MK Lazarides","year":"2016","unstructured":"Lazarides, M. K., Argyriou, C., Antoniou, G. A., Georgakarakos, E. & Georgiadis, G. S. Lack of evidence for use of heparin-bonded grafts in access surgery: a meta-analysis. Semin. Vasc. Surg. 29, 192\u2013197 (2016).","journal-title":"Semin. Vasc. Surg."},{"key":"333_CR115","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jvs.2015.01.056","volume":"62","author":"D Shemesh","year":"2015","unstructured":"Shemesh, D. et al. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access. J. Vasc. Surg. 62, 115\u2013122 (2015).","journal-title":"J. Vasc. Surg."},{"key":"333_CR116","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jvs.2011.09.012","volume":"55","author":"I Baek","year":"2012","unstructured":"Baek, I. et al. Paclitaxel coating of the luminal surface of hemodialysis grafts with effective suppression of neointimal hyperplasia. J. Vasc. Surg. 55, 806\u2013814.e1 (2012).","journal-title":"J. Vasc. Surg."},{"key":"333_CR117","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1093\/ndt\/gfl070","volume":"21","author":"BH Lee","year":"2006","unstructured":"Lee, B. H. et al. Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis. Nephrol. Dial. Transpl. 21, 2432\u20132438 (2006).","journal-title":"Nephrol. Dial. Transpl."},{"key":"333_CR118","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.jvs.2014.01.033","volume":"61","author":"I Baek","year":"2015","unstructured":"Baek, I. et al. Paclitaxel coating on the terminal portion of hemodialysis grafts effectively suppresses neointimal hyperplasia in a porcine model. J. Vasc. Surg. 61, 1575\u20131582.e1 (2015).","journal-title":"J. Vasc. Surg."},{"key":"333_CR119","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1093\/ndt\/gfr545","volume":"27","author":"I Baek","year":"2012","unstructured":"Baek, I. et al. Suppression of neointimal hyperplasia by sirolimus-eluting expanded polytetrafluoroethylene (ePTFE) haemodialysis grafts in comparison with paclitaxel-coated grafts. Nephrol. Dial. Transpl. 27, 1997\u20132004 (2012).","journal-title":"Nephrol. Dial. Transpl."},{"key":"333_CR120","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.jvs.2005.06.018","volume":"42","author":"C Cagiannos","year":"2005","unstructured":"Cagiannos, C. et al. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model. J. Vasc. Surg. 42, 980\u2013988 (2005).","journal-title":"J. Vasc. Surg."},{"key":"333_CR121","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00448708 (2011)."},{"key":"333_CR122","unstructured":"Medgadget.Angiotech Suspends Vascular Wrap Trial Enrollment. https:\/\/www.medgadget.com\/2008\/04\/angiotech_suspends_vascular_wrap_trial_enrollment.html (2008)."},{"key":"333_CR123","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.avsg.2019.12.002","volume":"66","author":"JJ Nguyen-Lee","year":"2019","unstructured":"Nguyen-Lee, J. J. et al. Clinical experience with gore hybrid vascular graft in complex revascularizations demonstrates safety and efficacy. Ann. Vasc. Surg. 66, 646\u2013653 (2019).","journal-title":"Ann. Vasc. Surg."},{"key":"333_CR124","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5301\/jva.5000696","volume":"18","author":"LF Gomez","year":"2017","unstructured":"Gomez, L. F. & Peden, E. K. Description and early outcomes of the hybrid graft for dialysis. J. Vasc. Access 18, 64\u201367 (2017).","journal-title":"J. Vasc. Access"},{"key":"333_CR125","first-page":"13","volume":"2014","author":"SM Gage","year":"2014","unstructured":"Gage, S. M. & Lawson, J. H. Challenging hybrid cases: how we do them. Endovasc. Today 2014, 13\u201316 (2014).","journal-title":"Endovasc. Today"},{"key":"333_CR126","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/1129729819874987","volume":"21","author":"SM Gage","year":"2020","unstructured":"Gage, S. M. et al. An immediate access dialysis graft designed to prevent needle-related complications: results from the initial pre-clinical studies. J. Vasc. Access 21, 328\u2013335 (2020).","journal-title":"J. Vasc. Access"},{"key":"333_CR127","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03645681 (2020)."},{"key":"333_CR128","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/0974-9233.148348","volume":"22","author":"JA Kammer","year":"2015","unstructured":"Kammer, J. A. & Mundy, K. M. Suprachoroidal devices in glaucoma surgery. Middle East Afr. J. Ophthalmol. 22, 45\u201352 (2015).","journal-title":"Middle East Afr. J. Ophthalmol."},{"key":"333_CR129","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1002\/bit.24559","volume":"109","author":"JD Bryers","year":"2012","unstructured":"Bryers, J. D., Giachelli, C. M. & Ratner, B. D. Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts. Biotechnol. Bioeng. 109, 1898\u20131911 (2012).","journal-title":"Biotechnol. Bioeng."},{"key":"333_CR130","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.actbio.2019.05.002","volume":"92","author":"F Kabirian","year":"2019","unstructured":"Kabirian, F., Brouki Milan, P., Zamanian, A., Heying, R. & Mozafari, M. Nitric oxide-releasing vascular grafts: a therapeutic strategy to promote angiogenic activity and endothelium regeneration. Acta Biomater. 92, 82\u201391 (2019).","journal-title":"Acta Biomater."},{"key":"333_CR131","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jvs.2004.07.007","volume":"40","author":"PS Fleser","year":"2004","unstructured":"Fleser, P. S. et al. Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts. J. Vasc. Surg. 40, 803\u2013811 (2004).","journal-title":"J. Vasc. Surg."},{"key":"333_CR132","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jvs.2016.10.080","volume":"65","author":"I Arhuidese","year":"2017","unstructured":"Arhuidese, I. et al. Bovine carotid artery biologic graft outperforms expanded polytetrafluoroethylene for hemodialysis access. J. Vasc. Surg. 65, 775\u2013782 (2017).","journal-title":"J. Vasc. Surg."},{"key":"333_CR133","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.jvs.2016.12.109","volume":"65","author":"DM Pineda","year":"2017","unstructured":"Pineda, D. M. et al. Bovine carotid artery xenografts for hemodialysis access. J. Vasc. Surg. 65, 1729\u20131734 (2017).","journal-title":"J. Vasc. Surg."},{"key":"333_CR134","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.jvs.2013.08.018","volume":"60","author":"W Wystrychowski","year":"2014","unstructured":"Wystrychowski, W. et al. First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access. J. Vasc. Surg. 60, 1353\u20131357 (2014).","journal-title":"J. Vasc. Surg."},{"key":"333_CR135","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/S0140-6736(09)60248-8","volume":"373","author":"TN McAllister","year":"2009","unstructured":"McAllister, T. N. et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 373, 1440\u20131446 (2009).","journal-title":"Lancet"},{"key":"333_CR136","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.ymthe.2018.04.003","volume":"26","author":"I Tzchori","year":"2018","unstructured":"Tzchori, I. et al. Improved patency of ePTFE grafts as a hemodialysis access site by seeding autologous endothelial cells expressing fibulin-5 and VEGF. Mol. Ther. 26, 1660\u20131668 (2018).","journal-title":"Mol. Ther."},{"key":"333_CR137","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/S0142-9612(03)00043-7","volume":"24","author":"G Matsumura","year":"2003","unstructured":"Matsumura, G., Hibino, N., Ikada, Y., Kurosawa, H. & Shin\u2019oka, T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 24, 2303\u20132308 (2003).","journal-title":"Biomaterials"},{"key":"333_CR138","doi-asserted-by":"publisher","first-page":"119577","DOI":"10.1016\/j.biomaterials.2019.119577","volume":"229","author":"WJ Geelhoed","year":"2020","unstructured":"Geelhoed, W. J. et al. A novel method for engineering autologous non-thrombogenic in situ tissue-engineered blood vessels for arteriovenous grafting. Biomaterials 229, 119577 (2020).","journal-title":"Biomaterials"},{"key":"333_CR139","doi-asserted-by":"publisher","first-page":"68ra9","DOI":"10.1126\/scitranslmed.3001426","volume":"3","author":"SLM Dahl","year":"2011","unstructured":"Dahl, S. L. M. et al. Readily available tissue-engineered vascular grafts. Sci. Transl. Med. 3, 68ra9 (2011).","journal-title":"Sci. Transl. Med."},{"key":"333_CR140","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/S0140-6736(16)00557-2","volume":"387","author":"JH Lawson","year":"2016","unstructured":"Lawson, J. H. et al. Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. Lancet 387, 2026\u20132034 (2016).","journal-title":"Lancet"},{"key":"333_CR141","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jss.2017.08.035","volume":"221","author":"RD Kirkton","year":"2018","unstructured":"Kirkton, R. D. et al. Susceptibility of ePTFE vascular grafts and bioengineered human acellular vessels to infection. J. Surg. Res. 221, 143\u2013151 (2018).","journal-title":"J. Surg. Res."},{"key":"333_CR142","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau6934","volume":"11","author":"RD Kirkton","year":"2019","unstructured":"Kirkton, R. D. et al. Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation. Sci. Transl. Med. 11, eaau6934 (2019).","journal-title":"Sci. Transl. Med."},{"key":"333_CR143","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02644941 (2020)."},{"key":"333_CR144","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03183245 (2020)."},{"key":"333_CR145","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejvs.2012.04.011","volume":"44","author":"SM Gage","year":"2012","unstructured":"Gage, S. M. et al. Multi-center experience of 164 consecutive Hemodialysis Reliable Outflow [HeRO] graft implants for hemodialysis treatment. Eur. J. Vasc. Endovasc. Surg. 44, 93\u201399 (2012).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"333_CR146","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jvs.2013.02.018","volume":"58","author":"JR Wallace","year":"2013","unstructured":"Wallace, J. R., Chaer, R. A. & Dillavou, E. D. Report on the hemodialysis reliable outflow (HeRO) experience in dialysis patients with central venous occlusions. J. Vasc. Surg. 58, 742\u2013747 (2013).","journal-title":"J. Vasc. Surg."},{"key":"333_CR147","first-page":"1","volume":"11","author":"MH Maqsood","year":"2019","unstructured":"Maqsood, M. H. & Rubab, K. Quality of life of patients using the hemodialysis reliable outflow (HeRO) graft in hemodialysis. Cureus 11, 1\u20138 (2019).","journal-title":"Cureus"},{"key":"333_CR148","unstructured":"Trump, D. J. Executive order on advancing American kidney health https:\/\/www.whitehouse.gov\/presidential-actions\/executive-order-advancing-american-kidney-health\/ (The White House, 2019)."},{"key":"333_CR149","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1681\/ASN.2015090976","volume":"27","author":"PG Linde","year":"2016","unstructured":"Linde, P. G. et al. Overcoming barriers in kidney health\u2013forging a platform for innovation. J. Am. Soc. Nephrol. 27, 1902\u20131910 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"333_CR150","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2215\/CJN.01140113","volume":"8","author":"P Archdeacon","year":"2013","unstructured":"Archdeacon, P., Shaffer, R. N., Winkelmayer, W. C., Falk, R. J. & Roy-Chaudhury, P. Fostering innovation, advancing patient safety: the kidney health initiative. Clin. J. Am. Soc. Nephrol. 8, 1609\u20131617 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"333_CR151","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2215\/CJN.02900317","volume":"13","author":"FP Hurst","year":"2018","unstructured":"Hurst, F. P., Lee, R. E., Thompson, A. M., Pullin, B. D. & Silverstein, D. M. FDA regulatory perspectives for studies on hemodialysis vascular access. Clin. J. Am. Soc. Nephrol. 13, 513\u2013518 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"333_CR152","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2215\/CJN.11531116","volume":"13","author":"GA Beathard","year":"2018","unstructured":"Beathard, G. A. et al. Definitions and end points for interventional studies for arteriovenous dialysis access. Clin. J. Am. Soc. Nephrol. 13, 501\u2013512 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"333_CR153","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2215\/CJN.13321216","volume":"13","author":"S Shenoy","year":"2018","unstructured":"Shenoy, S. et al. Clinical trial end points for hemodialysis vascular access: background, rationale, and definitions. Clin. J. Am. Soc. Nephrol. 13, 490\u2013494 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"333_CR154","unstructured":"Nexight Group. Kidney Health Initiative: Technology Roadmap for innovative approaches to renal replacement therapy https:\/\/www.asn-online.org\/membership\/BlastEmails\/files\/KHI_RRT_Roadmap1.0_FINAL_102318_web.pdf (2018)."},{"key":"333_CR155","unstructured":"Commins, J. HHS names KidneyX redesign phase 1 winners. HealthLeaders https:\/\/www.healthleadersmedia.com\/innovation\/hhs-names-kidneyx-redesign-phase-1-winners (2019)."},{"key":"333_CR156","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/0741-5214(93)90120-B","volume":"17","author":"WM Abbott","year":"1993","unstructured":"Abbott, W. M. et al. Evaluation and performance standards for arterial prostheses. J. Vasc. Surg. 17, 746\u2013756 (1993).","journal-title":"J. Vasc. Surg."},{"key":"333_CR157","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2215\/CJN.12011116","volume":"13","author":"M Allon","year":"2018","unstructured":"Allon, M. et al. Recommended clinical trial end points for dialysis catheters. Clin. J. Am. Soc. Nephrol. 13, 495\u2013500 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"333_CR158","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5301\/JVA.2011.6390","volume":"12","author":"M Chaudhry","year":"2011","unstructured":"Chaudhry, M. et al. Seeing eye to eye: the key to reducing catheter use. J. Vasc. Access 12, 120\u2013126 (2011).","journal-title":"J. Vasc. Access"},{"key":"333_CR159","unstructured":"Dorobant\u0327u, L. F., S\u0327tiru, O., Bulescu, C., Bubenek, S. & Iliescu, V. A. in Hemodialysis Ch. 30 (ed. Suzuki, H.) (IntechOpen, 2013)."},{"key":"333_CR160","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1523-1755.2002.kid551.x","volume":"62","author":"M Allon","year":"2002","unstructured":"Allon, M. & Robbin, M. L. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int. 62, 1109\u20131124 (2002).","journal-title":"Kidney Int."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-020-0333-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-020-0333-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-020-0333-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:17:31Z","timestamp":1629764251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-020-0333-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":160,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["333"],"URL":"https:\/\/doi.org\/10.1038\/s41581-020-0333-2","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,24]]},"assertion":[{"value":"21 July 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.H.L. is the CEO of Humacyte, Inc. and is a co-founder of InnAVasc. L.E.N. is the founder of Humacyte, Inc. P.R.-C. is a consultant and adviser for WL Gore, BD, Medtronic, Cormedix, Humacyte, Akebia, Vifor-Relypsa and Bayer; the founder and Chief Scientific Officer of Inovasc LLC; the founding co-chair of the Kidney Health Initiative; and currently a member of the steering committee of the KidneyX Innovation Accelerator. P.R.-C. is also a co-PI on phase II of NIH Small Business award programs with Cylerus.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}